California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

That’s why Duke University, the City of Durham and several barbershops are launching the Durham Impact Project. One goal is to engage with young men, attempting to steer them in a safe direction while ...

Late in the third quarter, blood visibly dripped from the jersey of Central Catholic senior Aniela Kwo, who needed to change ...

Some local governments across the state of West Virginia are cracking down on the regulations around beekeeping. Across the ...

A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...

On the eve of President Trump's tariffs, Reuters reported Honda would move production of the popular Civic to Indiana. Honda ...

Pope Francis was up and receiving therapy on Monday after apparently overcoming a setback in his recovery from pneumonia. The ...

A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.